Contribute Try STAT+ Today

What do dark chocolate, snake bites, and cats with irritable bowel disease have in common?

They’re all being taken on by the latest class of 13 startups announced on Wednesday by the San Francisco biotech accelerator IndieBio.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Biotech is but one of many applications for Quantum Dots.
    QTMM will be Quite The Money Maker in 2018. Don’t miss this baby Intel for the next generation of semiconductors at the atomic level.

Comments are closed.

Your daily dose of news in health and medicine

Privacy Policy